Herbal medicinal products and botanicals: why are clear boundaries necessary?
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: KELBER, Olaf (Steigerwald Arzneimittelwerk GmbH, Scientific Department, Darmstadt, Germany)
- Co-author(s): Kraft, Karin (Chair of Naturopathy, Universit, Rostock, Germany)
Armbr, Nicole (Bundesverband der Pharmazeutischen Industrie, Berlin, Germany)
Nauert, Christian (MCM Klosterfrau Vertriebsgesellschaft mbH, K, Germany)
Pohl, Rainer (Scientific Affairs, Rottapharm-Madaus GmbH, K, Germany)
Weiss, Gabriele (Pascoe Pharmazeutische Pr, Gie, Germany)
Steinhoff, Barbara (Bundesverband der Arzneimittelhersteller e.V., Bonn, Germany)
Kemper, Fritz H. (Universit, M, Germany)
Nieber, Karen (Institute of Pharmacy, University of Leipzig, Leipzig, Germany)
Background: In the EU, the boundaries between herbal medicinal products (HMPs) and dietary supplements of herbal origin (botanicals) are discussed politically. In this context the use of health claims based on traditional use was proposed for botanicals.
Aims: As this proposal would basically change the regulation of herbal products in the EU,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.